Imaging in children: augmenting accuracy and reducing risk
Lectures
1
Introduction by the moderator - Lorenzo E. Derchi, Genoa / IT
04:00
2
Pharmacokinetics, safety and efficacy of a new gadolinium-based contrast agent, gadopiclenol, in paediatric patients (2-17 years) undergoing MRI - Silvia Tsvetkova, Plovdiv / BG
08:00
3
Combined metabolic and functional tumour volumes on PET/MRI in neuroblastoma: complementary or redundant information by 18F-FDG uptake and diffusion restriction? - Maryanna Chaika, Tuebingen / DE
08:00
4
Prognostic impact of CT severity score in childhood cancer with SARS-CoV-2 - Amal Refaat, Cairo / EG
08:00
5
Accelerating whole-body MRI for follow-up and prevention of paediatric patients with cancer and cancer predisposition syndromes: preliminary results - Judith Herrmann, Tuebingen / DE
08:00
6
Dose levels for paediatric fluoroscopic imaging in the Netherlands - Goswin Croes, Hengelo / NL
08:00
7
Diagnostic value of abdominal follow-up sonography in paediatric polytrauma patients with inconspicuous initial computed tomography - Sophie-Charlotte Alt, Hamburg / DE
08:00
8
Assessment of cancer risk associated with increased radiation field sizes for neonates undergoing chest radiography - Wiam Elshami, Sharjah / AE